Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income (loss) from continuing operations	$ (2,662,187)	$ (1,140,014)
Adjustments to reconcile net loss to net cash provided (used) in Operating activities:
Depreciation and amortization	38,273	48,413
Amortization of discounts and deferred costs	183,765	386,721
Stock and warrants issued as payment for services	203,500	143,900
Warrant expense	376,550	705,537
Re-acquisition of distributorship	0	907,872
(Gain) loss on fair market value of derivative liabilities	941,928	(3,355,868)
Increase (decrease) in allowance for uncollectible notes receivable	0	493,233
Non-cash debt related costs	146,962	(18,560)
Changes in assets and liabilities:
(Increase) decrease in accounts receivable,	66,846	(149,409)
(Increase) decrease in inventory	(4,823)	(273,308)
(Increase) decrease in employee advances	(31,897)	20,733
(Increase) decrease in accrued interest receivable - related parties	0	(22,378)
(Increase) decrease in accrued interest receivable	0	(104,272)
(Increase) decrease in prepaids and other assets	(4,275)	(17,247)
(Increase) decrease in deferred compensation	41,550	309,450
Increase (decrease) in allowance for uncollectible interest	0	131,011
Increase (decrease) in accrued royalties	(521,988)	281,250
Increase (decrease) in accounts payable	(4,149)	255,914
Increase (decrease) in accrued liabilities	(198,976)	(71,238)
Increase (decrease) in accrued interest payable - related parties	38,561	12,964
Increase (decrease) in accrued interest payable	205,235	155,075
Net cash flows provided (used) in operating activities	(1,185,125)	(1,300,221)
Cash flows from investing activities:
Purchase of property and equipment	0	(2,060)
Proceeds from notes receivable - related parties	0	371,839
Net cash flows used in investing activities	0	369,779
Cash flows from financing activities:
Proceeds from notes payable - related parties	0	315,200
Payments on notes payable - related parties	0	(26,200)
Proceeds from notes payable	891,160	1,774,500
Payments on notes payable	(195,435)	(1,480,000)
Proceeds from debentures	0	347,500
Proceeds from sale of stock	0	15,248
Proceeds from exercise of warrants	5,760	0
Proceeds from stock subscriptions payable	569,000	0
Net cash flows provided by financing activities	1,270,485	946,248
Increase (decrease) in cash	85,360	15,806
Cash and cash equivalents, beginning of period	45,861	3,608
Cash and cash equivalents, end of period	131,221	19,414
Cash paid during the period for:
Interest	20,821	7,258
Income Taxes	0	0
Supplemental non-cash investing and financing activities:
Common stock issued for debt conversion	301,145	678,000
Derivative Liability reduced by stock issuance for debt conversion	342,987	723,923
Derivative Liability reduced by stock issuance for warrant exercise	74,188	0
Common stock issued for debt related costs	$ 5,500	$ 1,200